Marlborough Company Highlights Bi-Polar & Schizophrenia Treatments at the American College of Neuropsychopharmacology Meeting
editor The following is a press release summitted to SOURCE media through its business wire service *** MARLBOROUGH- Sunovion Pharmaceuticals Inc. announced this week new data and analyses of late-stage compounds…